Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3
出版年份 2015 全文链接
标题
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3
作者
关键词
-
出版物
HEPATOLOGY
Volume 63, Issue 1, Pages 63-73
出版商
Wiley
发表日期
2015-09-26
DOI
10.1002/hep.28255
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir
- (2015) Simone Susser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region
- (2015) Christoph Sarrazin et al. ANTIVIRAL RESEARCH
- All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study
- (2015) David R. Nelson et al. HEPATOLOGY
- Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
- (2015) K. Rajender Reddy et al. HEPATOLOGY
- The clinical features of patients with a Y93H variant of hepatitis C virus detected by a PCR invader assay
- (2015) Toshiki Kan et al. JOURNAL OF GASTROENTEROLOGY
- Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A
- (2015) Sakura Akamatsu et al. JOURNAL OF HEPATOLOGY
- Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies
- (2015) Oliver Lenz et al. JOURNAL OF HEPATOLOGY
- Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
- (2015) Susanna Naggie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update on hepatitis C virus resistance to direct-acting antiviral agents
- (2014) Eva Poveda et al. ANTIVIRAL RESEARCH
- Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
- (2014) Christophe Hézode et al. GUT
- Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection
- (2014) Mika Miura et al. HEPATOLOGY RESEARCH
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection
- (2014) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
- (2014) Michael Manns et al. LANCET
- Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C
- (2014) Simone Susser et al. PLoS One
- Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
- (2014) T. R. O'Brien et al. Open Forum Infectious Diseases
- Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
- (2013) Ole J Hamming et al. EMBO JOURNAL
- IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
- (2013) Stéphanie Bibert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin
- (2013) Eric G. Meissner et al. JOURNAL OF INFECTIOUS DISEASES
- Deep Sequencing Reveals Mutagenic Effects of Ribavirin during Monotherapy of Hepatitis C Virus Genotype 1-Infected Patients
- (2013) J. Dietz et al. JOURNAL OF VIROLOGY
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- Faldaprevir and Deleobuvir for HCV Genotype 1 Infection
- (2013) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
- (2012) J. Schreiber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor
- (2012) Zulema Plaza et al. ANTIVIRAL THERAPY
- Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assays
- (2012) T. Verbinnen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Innate immunity and HCV
- (2012) Markus H. Heim JOURNAL OF HEPATOLOGY
- Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment
- (2012) Doug J. Bartels et al. JOURNAL OF VIROLOGY
- Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1
- (2011) Richard E. Nettles et al. HEPATOLOGY
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- Distinct Functions of NS5A in Hepatitis C Virus RNA Replication Uncovered by Studies with the NS5A Inhibitor BMS-790052
- (2011) R. A. Fridell et al. JOURNAL OF VIROLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- HLA class I allele associations with HCV genetic variants in patients with chronic HCV genotypes 1a or 1b infection
- (2010) Christian Markus Lange et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)
- (2009) T. L. Kieffer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now